Amany M. Gad

1.5k total citations
58 papers, 1.1k citations indexed

About

Amany M. Gad is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Pharmacology. According to data from OpenAlex, Amany M. Gad has authored 58 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Pathology and Forensic Medicine and 8 papers in Pharmacology. Recurrent topics in Amany M. Gad's work include Chemotherapy-induced organ toxicity mitigation (8 papers), Chemotherapy-induced cardiotoxicity and mitigation (6 papers) and Tryptophan and brain disorders (5 papers). Amany M. Gad is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (8 papers), Chemotherapy-induced cardiotoxicity and mitigation (6 papers) and Tryptophan and brain disorders (5 papers). Amany M. Gad collaborates with scholars based in Egypt, Saudi Arabia and Netherlands. Amany M. Gad's co-authors include Hany H. Arab, Ahmed H. Eid, Samar S. Azab, Ola M. Abd El‐Raouf, Hala M. Fawzy, Sara A. Wahdan, Marwa M. Khalaf, Reem N. El‐Naga, Naglaa Assaf and Mohammed F. El-Yamany and has published in prestigious journals such as International Journal of Molecular Sciences, Biochemical Pharmacology and Life Sciences.

In The Last Decade

Amany M. Gad

54 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amany M. Gad Egypt 20 257 156 135 131 114 58 1.1k
Amira M. Abo‐Youssef Egypt 20 326 1.3× 190 1.2× 157 1.2× 78 0.6× 116 1.0× 70 1.2k
Mustafa Çekmen Türkiye 21 290 1.1× 267 1.7× 135 1.0× 151 1.2× 125 1.1× 58 1.5k
Adnan Somay Türkiye 18 244 0.9× 302 1.9× 159 1.2× 110 0.8× 141 1.2× 64 1.3k
Fereshteh Talebpour Amiri Iran 19 218 0.8× 172 1.1× 120 0.9× 53 0.4× 89 0.8× 110 1.1k
Mohammed M. Al‐Harbi Saudi Arabia 25 422 1.6× 110 0.7× 130 1.0× 87 0.7× 68 0.6× 46 1.4k
Jamshid Karimi Iran 24 480 1.9× 98 0.6× 114 0.8× 112 0.9× 75 0.7× 82 1.5k
‬Rana Keyhanmanesh Iran 24 314 1.2× 72 0.5× 179 1.3× 214 1.6× 73 0.6× 92 1.5k
Şemsettin Şahin Türkiye 20 246 1.0× 147 0.9× 83 0.6× 109 0.8× 58 0.5× 41 1.1k
Mohamed A. Haidara Saudi Arabia 19 347 1.4× 86 0.6× 115 0.9× 64 0.5× 94 0.8× 88 1.4k
Yuh‐Mou Sue Taiwan 19 300 1.2× 122 0.8× 89 0.7× 100 0.8× 124 1.1× 69 1.5k

Countries citing papers authored by Amany M. Gad

Since Specialization
Citations

This map shows the geographic impact of Amany M. Gad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amany M. Gad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amany M. Gad more than expected).

Fields of papers citing papers by Amany M. Gad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amany M. Gad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amany M. Gad. The network helps show where Amany M. Gad may publish in the future.

Co-authorship network of co-authors of Amany M. Gad

This figure shows the co-authorship network connecting the top 25 collaborators of Amany M. Gad. A scholar is included among the top collaborators of Amany M. Gad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amany M. Gad. Amany M. Gad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abu‐Dief, Ahmed M., et al.. (2025). Methylene Blue Mitigates Doxorubicin-Induced Cardiotoxicity via KEAP1/NRF2/GPX-4/Caspase3 Modulation. International Journal of Molecular Sciences. 26(16). 7680–7680. 2 indexed citations
2.
Gad, Amany M., et al.. (2025). Hesperidin Reduces Hepatic Injury Induced by Doxorubicin in Rat Model Through Its Antioxidative and Anti‐Inflammatory Effects, Focusing on SIRT‐1/NRF‐2 Pathways. Journal of Biochemical and Molecular Toxicology. 39(9). e70465–e70465. 3 indexed citations
3.
4.
5.
Gad, Amany M., et al.. (2024). Biosimilars production in Africa opportunities & challenges. Regulatory Toxicology and Pharmacology. 149. 105626–105626.
6.
Arab, Hany H., et al.. (2024). Targeting JAK2/STAT3, NLRP3/Caspase-1, and PK2/PKR2 Pathways with Arbutin Ameliorates Lead Acetate-Induced Testicular Injury in Rats. Pharmaceuticals. 17(7). 909–909. 10 indexed citations
7.
Ali, Azza A., et al.. (2023). Impact of peroxisome proliferator activated receptor agonist drugs in a model of nephrotoxicity in rats. Journal of Biochemical and Molecular Toxicology. 37(6). e23350–e23350. 5 indexed citations
8.
Gad, Amany M., et al.. (2023). Naringenin alleviate reproductive toxicity evoked by lead acetate via attenuation of sperm profile and biochemical alterations in male Wistar rat: Involvement of TGFβ/AKT/mTOR pathway. Journal of Biochemical and Molecular Toxicology. 37(6). e23335–e23335. 8 indexed citations
9.
Ahmed, Amany A.E., et al.. (2022). Polydatin combats methotrexate‐induced pulmonary fibrosis in rats: Involvement of biochemical and histopathological assessment. Journal of Biochemical and Molecular Toxicology. 36(5). e23019–e23019. 11 indexed citations
10.
Wahdan, Sara A., et al.. (2021). Saxagliptin ameliorated the depressive-like behavior induced by chronic unpredictable mild stress in rats: Impact on incretins and AKT/PI3K pathway. European Journal of Pharmacology. 912. 174602–174602. 16 indexed citations
11.
12.
Gad, Amany M., et al.. (2019). Venlafaxine alleviates complete Freund's adjuvant-induced arthritis in rats: Modulation of STAT-3/IL-17/RANKL axis. Life Sciences. 226. 68–76. 19 indexed citations
13.
Mantawy, Eman M., et al.. (2019). Activation of pCREB/Nrf-2 signaling mediates re-positioning of liraglutide as hepato-protective for methotrexate -induced liver injury (MILI). Food and Chemical Toxicology. 132. 110719–110719. 16 indexed citations
14.
Gad, Amany M.. (2018). Study on the influence of caffeic acid against sodium valproate–induced nephrotoxicity in rats. Journal of Biochemical and Molecular Toxicology. 32(8). e22175–e22175. 12 indexed citations
15.
16.
Gad, Amany M., et al.. (2018). Modulatory effects of some natural products on hepatotoxicity induced by combination of sodium valproate and paracetamol in rats. Journal of Biochemical and Molecular Toxicology. 32(7). e22162–e22162. 5 indexed citations
17.
Gad, Amany M., et al.. (2017). Curcumin ameliorates diclofenac sodium‐induced nephrotoxicity in male albino rats. Journal of Biochemical and Molecular Toxicology. 31(10). 37 indexed citations
18.
Ali, Azza A., et al.. (2017). Nephrotoxicity and Hepatotoxicity Induced by Chronic Aluminium Exposure in Rats: Impact of Nutrients Combination versus Social Isolation and Protein Malnutrition. 4(1). 4 indexed citations
19.
Gad, Amany M., et al.. (2017). Renoprotective effects of montelukast in an experimental model of cisplatin nephrotoxicity in rats. Journal of Biochemical and Molecular Toxicology. 31(12). 17 indexed citations
20.
Khalaf, Marwa M., et al.. (2017). Evaluation of the possible nephroprotective effects of vitamin E and rosuvastatin in amikacin‐induced renal injury in rats. Journal of Biochemical and Molecular Toxicology. 31(11). 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Amira M. Abo‐Youssef Breakdown of academic impact, for papers by Mustafa Çekmen Breakdown of academic impact, for papers by Adnan Somay Breakdown of academic impact, for papers by Fereshteh Talebpour Amiri Breakdown of academic impact, for papers by Mohammed M. Al‐Harbi Breakdown of academic impact, for papers by Jamshid Karimi Breakdown of academic impact, for papers by ‬Rana Keyhanmanesh Breakdown of academic impact, for papers by Şemsettin Şahin Breakdown of academic impact, for papers by Mohamed A. Haidara Breakdown of academic impact, for papers by Yuh‐Mou Sue
Rankless by CCL
2026